About Us
AM Aesthetics, an award-winning, independent medical aesthetic clinic in the UK, boasts over 30 years of experience in the industry.
AM Aesthetics is a leading, independent medical aesthetic clinic in the UK, recognised for its excellence.
Founded by Professor Haq MBBS BSc PhD DIC MRCP(UK) and Alexandra Mills-Haq Bsc (Hons)PGD RGN RHV INP, who bring over 30 years of experience in medical aesthetics, we are dedicated to providing cutting-edge, non-surgical treatments for both men and women, specializing in natural facial rejuvenation that enhances your features subtly.
Our commitment is to provide top-tier cosmetic treatments and exceptional customer service in a warm, welcoming, and relaxed setting. We aim to help you look and feel your best through our deep expertise in aesthetic and wellness medicine, a refined sense of beauty, and a safe, ethical, and comprehensive approach to care. We welcome you at our clinics located in London and Belfast, where we offer a wide array of aesthetic, wellness, dermatological, and nutritional services.
BSc (Hons) PGD INP
Alex graduated from Queen’s University, Belfast. Alex studied both Nursing and Law. She has been working in the field of aesthetic medicine for over a decade and is the founder of AM Aesthetics, one of Belfast’s busiest aesthetic clinics with an outstanding reputation for “natural results”
Following the birth of her son, Alex is spending more time in London, were she is now based in 10 Harley Street W1.
Alex has a keen interest in facial anatomy and education. She has attended master classes in London, Paris , Monaco and Asia. She has been a trainer and KOL for number of pharmaceutical companies in the UK and Ireland. She is published author in the realm of aesthetic medicine and is a member of the Editorial Board of the Journal of Aesthetic Nursing. Alex is a member of the British Association of Cosmetic Nurses and a nurse prescriber.
Alex takes a global approach to managing ageing, delivering natural results. She firmly agrees with “a less is more” approach.
She had recently been listed in Glamour Uk as one of the Top clinics in the Uk.
She has also been featured in the Daily Mail , Vogue and many more.
MBBS BSc PhD DIC MRCP(UK) Consultant Physician
He is a key opinion leader for Galderma, and currently the chief medical and scientific officer of a UK ABPI registered biopharmaceutical company developing a platform for the treatment of Alzheimer’s disease.
He has recently presented a lecture on neurotoxins at Aesthetic Conference UK in 2019 and worked closely with Saatchi and Saatchi on improving awareness of neurotoxins to clinicians and the public.
He is the chairman of the Association of PDO threads UK and chairs the UK’s largest Aesthetic Conference (FACE) on their threads agenda.
Alongside his medical practice he has been working in the field of anti-ageing and aesthetics for over a decade. He has co-ordinated and overseen two MHRA registered phase IIa double blind placebo controlled clinical trials undertaken in the UK. He notably achieved the successful award of an Orphan Drug Designation from the US FDA in 2014.
Prof. Haq has worked closely with PwC and Rothschilds in the past, as part of a biopharma valuation process and with Vertex Pharmaceuticals.
Prof. Haq trained at Guy’s Hospital, Hammersmith and the Royal Brompton Hospitals, Imperial College University, Massachusetts General Hospital, Harvard Medical School, and Tufts University in Boston. Following his medical training he completed a PhD at Harvard Medical School/Mass General in the field of cell signal transduction. The cutting-edge work has provided insight into how cells communicate, age and have led to the development of a series of signal effector inhibitors.
He has published over 100 peer-reviewed scientific articles/abstracts in e.g., Proceedings of the National Academy of Science, Ann Rheum Diseases, Journal of Clinical Investigations, Circulation, Arthritis Research and Therapy, and Nature Medicine. He has received multiple national and international awards/ fellowships/honours from the Medical Research Council, Welcome Trust, Zeneca Pharmaceuticals, American Heart Association, Heart Failure Society of America.
Keep up to date with all AM Aesthetics press and news.
HArmonyCa is a first-in-class, dual-action, synthetic non-pyrogenic biodegradable hybrid dermal filler composed of calcium hydroxyapatite (CAHa) (55.5%) and cross-linked...
Alexandra Mills and Professor Syed Haq provide an overview of lip augmentation procedures using hyaluronic acid-based dermal filler, injection...
Sciton Moxi utilises laser technology with a wavelength of 1927nm. This wavelength is designed to target the superficial layers...
As aesthetic nurses, we find ourselves at the forefront of an ever-evolving field, where innovation and patient-centered care intersect....
